ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Research Note

A metabolite of prostaglandin D2, 11β-prostaglandin F (11β-PGF), in exhaled breath condensate and serum of asthmatics with airway hyperresponsiveness to distilled water

[version 1; peer review: 2 not approved]
PUBLISHED 09 Mar 2016
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

Abstract

This study aims at identifying prostaglandin D2 (PGD2) involvement in osmotic airway hyperresponsiveness of asthmatics. PGD2 primary plasma metabolite, 11β-PGF, was analyzed in exhaled breath condensate (EBC) in response to ultrasonically nebulized distilled water (UNDW) and in serum in asthmatics with different airway response to the hypoosmotic stimulus. The total group of asthmatics (n=27) had a lower basal level of 11β-PGF (0.38±0.13 pg/ml, mean±SEM) in EBC compared to a group of healthy subjects (0.86±0.31 pg/ml, n=5), which decreased following the UNDW challenge to 0.30±0.09 and 0.53±0.12, respectively. The group of asthmatics with airway hyperresponsiveness to UNDW (≥10% FEV1 drop from baseline, n=14) had a lower concentration of the metabolite (0.28±0.14 pg/ml) as compared to the group without hyperresponsiveness (0.49±0.31 pg/ml, n=10). The 11β-PGF concentration decreased in the both groups after the challenge: 0.20±0.04 and 0.23±0.07 pg/ml in the groups with and without hyperresponsiveness to UNDW, respectively . Serum content of 11β-PGF was ranging from 0 to 61 pg/ml in asthmatics (n=17) and from 7.3 to 85.4 pg/ml in healthy subjects (n=8). It was lower in the group with airway hyperresponsiveness to UNDW (8.4±1.7 pg/ml, n=9) than in the group without the hyperresponsiveness (21.0±8.8 pg/ml, n=8). The obtained results do not support the involvement of PGD2 in the pathophysiology of asthma with airway hyperresponsiveness to a hypoosmotic stimulus unless other conversions of the prostaglandin occur in the airway under these conditions with formation of metabolites different from 11β-PGF.

Keywords

Asthma, airway osmotic hyperresponsiveness, exhaled breath condensate, prostaglandin D2, 11β-prostaglandin F2α

Introduction

Prostaglandin D2 (PGD2) is produced by mast cells and macrophages increasing in response to allergen exposure. In asthmatics, PGD2 affects the airways by causing bronchoconstriction, vasodilation, increasing capillary permeability and mucous production1. The role of the prostaglandin in asthmatics with osmotic airway hyperresponsiveness is ill-defined. PGD2 is an unstable compound rapidly metabolized with 11β-PGF being its primary plasma metabolite. The aim of this study was estimation of 11β-PGF in exhaled breath condensate (EBC) in response to ultrasonically nebulized distilled water (UNDW) and serum in asthmatics with different airway response to the hypoosmotic stimulus.

Methods

The study protocol was approved by the Biomedical Ethics Committee of the Far Eastern Scientific Center of Physiology and Pathology of Respiration (permit #91-1 of 12.01.2015). 39 patients with mild to moderate asthma and 13 healthy subjects participated in the study. The patients were recruited from the Center’s in-patient facilities or invited for follow-up checks. EBC was collected from 27 asthmatics and 5 healthy subjects before and after 3 min provocation with UNDW. Aerosol (the particle size range 0.5–10 μm, average particle size 3 μm) was generated by a Thomex L-2 ultrasonic nebulizer (Poland) operated at 4.5 ml/min. The hypoosmolar challenge test consisted of two consecutive inhalations for 3 min each. The first inhalation was with 30 ml of isotonic solution (0.9% NaCl), and the second with the same volume of distilled water. The temperature of the solution was maintained at 37.3°C. During the inhalation, a participant used a nose-clip and was breathing in a calm manner through a mouthpiece connected via a two-way valve to the container with a solution. Lung function testing was conducted with a spirometer Easy on-PC (ndd Medizintechnik AG, Switzerland) before the provocation test (baseline) and at 1 and 5 min of the recovery period. A drop in forced expiratory volume in 1 sec (ΔFEV1) of 10% or more from baseline after inhalation with UNDW was considered as airway hyperresponsiveness to the hypoosmotic stimulus. Patients who experienced airway responsiveness to isotonic solutions (n=3) were excluded from the test with UNDW, and they were not included in any group except the total group of asthmatics. Patients who experienced any airway responsiveness were given 2 doses of a selective β2-adrenoceptor agonist to prevent bronchoconstriction. EBC was collected during tidal breathing with a condensing device ECoScreen 2 (Erich Jaeger, Germany). Serum was obtained from 17 patients and 8 healthy subjects before the provocation test. The collected samples were stored at -70°C until analysis. The concentration of 11β-PGF was measured by 11β-prostaglandin F EIA kit (No. 516521, Cayman Chemical Company, USA) in EBC after freeze-drying and in serum after purification by solid phase extraction on C18 cartridges (Strata C18-E, 55 μm, 70A, 500 mg/6 ml, Phenomenex, USA) as recommended by the manufacturer [Cayman’s kit booklet. URL: https://www.caymanchem.com/pdfs/516521.pdf]. The EIA kit utilizes 11β-PGF-specific rabbit antiserum, and mouse anti-rabbit monoclonal antibody. Each sample was assayed in duplicate. The optical densities of the samples were used to calculate the concentrations of 11β-PGF using an automated Excel spreadsheet [A. Swart 2012–2015. URL: http://www.rheumatologie-neuss.net/index_files/RheumatologieNeuss13.htm].

Analysis of the data was performed using standard methods of variational statistics. Statistical differences between groups were calculated by Student’s t test or by the nonparametric criteria of Mann-Whitney and Kolmogorov-Smirnov tests in the case of non-Gaussian distribution of variables (Statistica 8.0, StatSoft Inc., Tulsa, OK, USA, 2008).

Results

Standard pg/ml%B/B0
0100
0.25690.6
0.6475.8
1.671.3
4.169
10.253.3
Dataset 1.Data for calibration curves.
Standard Bound/Maximum Bound (%B/B0) values were obtained for the concentrations of the standard (11β-PGF, pg/ml) which were used to build calibration curves for calculations of 11β-PGF content in EBC (Table 1) and serum (Table 2) samples. The values were produced with different EIA kits on different days.
Group of subjects and EBC sample # Provocation with UNDW11?-PGF2? pg/ml%?FEV1 from baselineNote
Subjects with asthma
24Before0.332N.D.Reaction to 0.9% NaCl
After0.403
31Before0.488-15
After0.232
34Before1.063N.D.Reaction to 0.9% NaCl
After2.323
40Before0.55-10
After0.251
44Before0.341-2.8
After0.649
45Before0.609-3.1
After0.446
47Before0-7.4
After0.079
50Before0.5271.5
After0.258
56Before0.246-43
After0.241
60Before3.092-7.1
After0.302
73Before0.08-3.7
After0.085
76Before0.041-9.7
After0.311
78Before0.096-10
After0.06
80Before0.107-3.2
After0.066
81Before0.023.8
After0.082
82Before0.084N.D.Reaction to 0.9% NaCl
After0.162
83Before0.15-45
After0.157
84Before0.0471.9
After0.054
87Before0.036-10
After0.042
89Before0.125-11
After0.284
98Before0.052-27
After0.079
99Before0.007-74
After0.367
100Before1.875-13
After0.388
102Before0.081-42
After0.04
108Before0.101-24
After0.059
112Before0.031-15
After0.179
120Before0.128-26
After0.466
Healthy subjects
109Before0.447N.D.
After0.589
113Before0.557N.D.
After0.557
115Before0.323N.D.
After0.205
118Before1.196N.D.
After0.472
127Before1.776N.D.
Dataset 2.11β-PGF2α content (pg/ml) in exhaled breath condensate (EBC) of individual subjects before and after provocation with ultrasonically nebulized distilled water and change in forced expiratory volume in 1 sec (% ΔFEV1 from baseline) after the provocation.
N.D. – not determined; UNDW - ultrasonically nebulized distilled water.Note: Patients who had reaction to 0.9% NaCl were excluded from the test with ultrasonically nebulized distilled water.
Group of subjects and serum sample # 11?-PGF2? pg/ml%?FEV1 from baseline
Subjects with asthma
738.1-3.7
805.8-45
8155.81.9
13717.1-11
1464.8-15
8211.815.8
8711.9-5.6
899.4-6.8
974.41.3
997.5-14.1
10012.8-21
10261.1-2
10310-19
1047.2-19
1275.62.4
13010.4-25
1310-11
Healthy subjects
987.3N.D.
1089.4N.D.
10922.2N.D.
11224.3N.D.
11385.4N.D.
11516.3N.D.
11883.4N.D.
Dataset 3.11β-PGF2α content (pg/ml) in serum of individual subjects before provocation with ultrasonically nebulized distilled water and change in forced expiratory volume in 1 sec (% ΔFEV1 from baseline) after the provocation (if applicable).
N.D. – not determined

The level of 11β-PGF in EBC was below the announced detection limit (80% B/B0) of the kit (5.5 pg/ml). For the estimation of the 11β-PGF level in EBC before and after the provocation test and comparison of the changes in the groups of healthy subjects and asthmatics with and without airway hyperresponsiveness to UNDW, calibration curves were built using the 11β-PGF standard in the range of 0–25.6 pg/ml with additional dilutions of the standard down to 0.64 and 0.256 pg/ml and plotting %B/B0 vs. 11β-PGF concentration. Obtained values of %B/B0 for the dilutions were different from 100% (Dataset 1, Table 1).

Table 1. 11β-PGF content (pg/ml) in EBC and serum of subjects with different responsiveness to UNDW (values indicate number of subjects, n, range/mean±SEM).

Asthmatics, total
group
Asthmatics with
AHR to UNDW
Asthmatics without
AHR to UNDW
Healthy subjects
EBC
Before provocationn=27
0.00–3.09/0.38±0.13
n=14
0.01–1.88/0.28±0.14
n=10
0.00–3.09/0.49±0.31
n=5
0.32–1.79/0.86±0.31
After provocationn=27
0.04–2.32/0.30±0.09
n=14
0.04–0.47/0.20±0.04
n=10
0.05–0.65/0.23±0.07
n=5
0.21–0.85/0.53±0.12
Serum
Before provocationn=17
0.0–61.1/14.3±4.3
n=9
0.0–17.1/8.4±1.7
n=8
4.4–61.1/21.0±8.8
n=8
7.3–85.4/33.7±12.1

Abbreviations: AHR – airway hyperresponsiveness; EBC – exhaled breath condensate; SEM – standard error of mean; UNDW – ultrasonically nebulized distilled water

As a result, the calculated content of 11β-PGF in EBC was in the range of 0–3.1 pg/ml (Table 1). The total group of asthmatics had a lower basal level of 11β-PGF (0.38±0.13 pg/ml, mean±SEM) compared to the group of healthy controls (0.86±0.31 pg/ml), which further decreased following the UNDW challenge to 0.30±0.09 and 0.53±0.12, respectively. The group of asthmatics with airway hyperresponsiveness to UNDW was found to have a lower concentration of the metabolite (0.28±0.14 pg/ml) as compared to the group without the hyperresponsiveness (0.49±0.31 pg/ml). The 11β-PGF concentration decreased in both groups after the challenge: 0.20±0.04 and 0.23±0.07 pg/ml in the groups with and without hyperresponsiveness to UNDW, respectively.

The content of 11β-PGF in serum was higher ranging from 0 to 61 pg/ml in the total group of asthmatics and from 7.3 to 85.4 in healthy subjects (Table 1). Once again, it was lower on average in the total group of asthmatics than in the healthy subjects (14.3±4.3 vs. 33.7±12.1 pg/ml), and lower in the group with airway hyperresponsiveness to UNDW (8.4±1.7 pg/ml) than in the group without hyperresponsiveness (21.0±8.8 pg/ml). Due to the high variation of 11β-PGF content in the subjects, all differences were statistically insignificant (p>0.05).

Since prostaglandin D2 is considered to be a mast cell- and macrophage-specific eicosanoid, the lack of an increase in the concentration of its major metabolite 11β-PGF found in the present study suggests a diminished role of these immune cells in the pathogenesis of the inflammatory reaction in asthma patients with osmotic airway hyperresponsiveness. However, the formation of different metabolites of PGD2, apart from 11β-PGF, have been reported2 which may possess different physiological activities.

Conclusion

The obtained results do not support the involvement of PGD2 in the pathophysiology of asthma with airway hyperresponsiveness to a hypoosmotic stimulus unless other conversions of the prostaglandin occur in the airway under these conditions with formation of metabolites different from 11β-PGF. It would be interesting to investigate the level of other possible metabolites of PGD2.

Data availability

F1000Research: Dataset 1. Data for calibration curves, 10.5256/f1000research.8084.d1154173

F1000Research: Dataset 2. 11β-PGF content (pg/ml) in exhaled breath condensate (EBC) of individual subjects before and after provocation with ultrasonically nebulized distilled water and change in forced expiratory volume in 1 sec (% ΔFEV1 from baseline) after the provocation, 10.5256/f1000research.8084.d1154184

F1000Research: Dataset 3. 11β-PGF content (pg/ml) in serum of individual subjects before provocation with ultrasonically nebulized distilled water and change in forced expiratory volume in 1 sec (% ΔFEV1 from baseline) after the provocation (if applicable), 10.5256/f1000research.8084.d1154195

Consent

The study protocol was approved by the Biomedical Ethics Committee of the Far Eastern Scientific Center of Physiology and Pathology of Respiration (permit #91-1 of 12.01.2015), and the participants gave written informed consent.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 09 Mar 2016
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Nekrasov EV, Perelman JM, Naumov DE et al. A metabolite of prostaglandin D2, 11β-prostaglandin F (11β-PGF), in exhaled breath condensate and serum of asthmatics with airway hyperresponsiveness to distilled water [version 1; peer review: 2 not approved]. F1000Research 2016, 5:307 (https://doi.org/10.12688/f1000research.8084.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 09 Mar 2016
Views
14
Cite
Reviewer Report 09 Feb 2017
Giuseppe Santini, Department of Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Rome, Italy 
Not Approved
VIEWS 14
The critical point of this article is the detection limit of the ELISA KIT used. The concentration of metabolite measured in EBC was too much low. I suggest to concentrate the sample by evaporation under vacuum, or use an another ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Santini G. Reviewer Report For: A metabolite of prostaglandin D2, 11β-prostaglandin F (11β-PGF), in exhaled breath condensate and serum of asthmatics with airway hyperresponsiveness to distilled water [version 1; peer review: 2 not approved]. F1000Research 2016, 5:307 (https://doi.org/10.5256/f1000research.8696.r20065)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
15
Cite
Reviewer Report 01 Nov 2016
Andras Bikov, Department of Pulmonology, Semmelweis University, Budapest, Hungary 
Not Approved
VIEWS 15
I read the article with great interest. Lipid metabolites play a role in the pathophysiology of asthma and their changes during different stimuli are of interest.
  1. The critical point of the article is that the EBC
... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Bikov A. Reviewer Report For: A metabolite of prostaglandin D2, 11β-prostaglandin F (11β-PGF), in exhaled breath condensate and serum of asthmatics with airway hyperresponsiveness to distilled water [version 1; peer review: 2 not approved]. F1000Research 2016, 5:307 (https://doi.org/10.5256/f1000research.8696.r17321)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 09 Mar 2016
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.